Wen-Ji Dong | Agricultural and Biological Sciences | Best Researcher Award

Dr. Wen-Ji Dong | Agricultural and Biological Sciences | Best Researcher Award

Washington State University | United States

Author Profile

Scopus

Google Scholar

Early Academic Pursuits 🎓

Dr. Wen-Ji Dong embarked on his academic journey with a deep passion for chemistry and biophysics. He earned his B.S. and M.S. degrees in Chemistry from Lanzhou University, P.R. China, under the mentorship of Prof. Rudong Yang. His doctoral research at Birkbeck College, University of London, focused on physical chemistry, guided by Prof. Colin D. Flint. Further strengthening his expertise, he pursued postdoctoral training in biophysics at the University of Western Ontario and biochemistry at the University of Alabama at Birmingham. These formative years provided him with a multidisciplinary foundation, setting the stage for groundbreaking contributions to bioengineering and cardiac muscle research.

Professional Endeavors 🏛️

Dr. Dong's professional career spans multiple prestigious institutions. His tenure at Washington State University (WSU) has been particularly influential, where he has risen through the ranks from Assistant Professor to Full Professor in the Voiland School of Chemical Engineering and Bioengineering. Before joining WSU, he served as a Research Assistant Professor and Research Instructor at the University of Alabama at Birmingham, refining his expertise in protein and cellular engineering. His career reflects an unwavering commitment to advancing both research and education in bioengineering.

Contributions and Research Focus 🔍

Dr. Dong's research addresses critical challenges in cardiac muscle regulation, microbial extracellular vesicles, and diagnostic technologies. His key research objectives include:

  • Understanding Myocardial Function: Investigating fundamental mechanisms governing heart muscle function under healthy and diseased conditions.
  • Developing Advanced Biosensors: Creating unique diagnostic technologies for rapid disease detection at the point of care.
  • Microbial Extracellular Vesicles: Exploring their roles in intracellular communication and potential applications in microbial infection control.
  • Innovative Antibiotic Alternatives: Engineering microbial EV-based antibiotics to combat bacterial and fungal infections.

His interdisciplinary approach integrates bioengineering, fluorescence spectroscopy, biophotonics, and microfluidics, positioning him at the forefront of biomedical research.

Accolades and Recognition 🏆

Dr. Dong’s contributions have been widely recognized through various awards and editorial roles:

  • Outstanding Research Award from Washington State University.
  • Nominee for the Anjan Bose Research Award in the College of Engineering and Architecture.
  • Muscular Dystrophy Association Research Fellowship, highlighting his impact on muscle physiology research.
  • China-British Technology Collaboration Scholarship, recognizing his early academic excellence.
  • Editorial Roles in esteemed journals, including Frontiers in Striated Muscle Physiology, Biosensors, and Frontiers in Bioengineering and Biotechnology.
  • Invited Speaker at the Gordon Research Conference, a prestigious forum for scientific exchange.

His research publications, exceeding 148 in total, have garnered thousands of citations, reflecting his global academic impact.

Impact and Influence 🌍

Dr. Dong's research has significantly shaped the fields of bioengineering and cardiac physiology. His advancements in protein engineering, biosensors, and microbial vesicle studies have influenced both academia and industry. Through his mentorship at WSU, he has trained a new generation of researchers, equipping them with cutting-edge skills to drive future innovations.

Legacy and Future Contributions 🚀

Dr. Wen-Ji Dong’s legacy lies in his interdisciplinary approach to solving biomedical challenges. Moving forward, his work will continue to:

  • Refine diagnostic technologies for faster, more accurate disease detection.
  • Develop new microbial EV-based treatments, offering alternatives to traditional antibiotics.
  • Expand research on cardiac muscle regulation, contributing to novel therapies for heart diseases.
  • Inspire and mentor future scientists, ensuring sustained progress in bioengineering.

Dr. Dong’s dedication to research and education ensures that his influence will be felt for generations, cementing his reputation as a leader in bioengineering and biomedical innovation.

Publications


  •  📄 Dual Roles of the Conditional Extracellular Vesicles Derived from Pseudomonas aeruginosa Biofilms: Promoting and Inhibiting Bacterial Biofilm Growth
    Author(s): Marwa Gamal Saad, Haluk Beyenal, Wen-Ji Dong
    Journal: Biofilms
    Year: 2024


  •  📄 Dual Roles of the Conditional Exosomes Derived from Pseudomonas aeruginosa Biofilms: Promoting and Inhibiting Bacterial Biofilm Growth
    Author(s): Marwa Gamal Saad, Haluk Beyenal, Wen-Ji Dong
    Journal: bioRxiv
    Year: 2023


  •  📄 Exosomes as Powerful Engines in Cancer: Isolation, Characterization and Detection Techniques
    Author(s): Marwa Gamal Saad, Haluk Beyenal, Wen-Ji Dong
    Journal: Biosensors
    Year: 2021


  •  📄 Consensus Statement: Standardized Reporting of Power-Producing Luminescent Solar Concentrator Performance
    Author(s): Chenchen Yang, Wen-Ji Dong, Richard R. Lunt, et al.
    Journal: Joule
    Year: 2022


  •  📄 A Preliminary Investigation on the Photothermal Properties of Luminescent Solar Concentrators
    Author(s): Y. Li, Y. Sun, Y. Zhang, Wen-Ji Dong
    Journal: Optics
    Year: 2021


 

Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Qingdao University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Peng Chen's journey in medical research began with a strong foundation in clinical medicine and biomedical sciences. She earned her Bachelor of Medicine degree from Taishan Medical College (1999-2004), where she gained essential medical knowledge and clinical training. Her pursuit of advanced expertise led her to Capital University of Medical Sciences (2004-2007), where she obtained a Master of Science degree, focusing on medical research methodologies and specialized clinical studies. To further deepen her understanding and expertise, she pursued a Doctor of Medicine (2009-2012) at Qingdao University, refining her specialization in ophthalmology and regenerative medicine.

Professional Endeavors 🔬

After completing her master's degree, Prof. Chen embarked on her professional career at the Shandong Eye Institute (2007-2016), a renowned institution dedicated to ophthalmology research. During her tenure, she made significant contributions to vision sciences and ocular disease research, strengthening her expertise in eye-related disorders. In 2016, she transitioned to Qingdao University, where she currently serves as a leading researcher and faculty member. Her role at the university allows her to conduct cutting-edge research on ophthalmology and liver regeneration, mentor young medical scientists, and contribute to the advancement of medical science.

Contributions and Research Focus 🔍

Prof. Chen's research has significantly impacted liver regeneration, macrophage efferocytosis, and ophthalmology, particularly in understanding cellular mechanisms and disease pathophysiology. Some of her key contributions include:

  • Liver Regeneration and Macrophage Efferocytosis: Her recent studies have explored the NLRP3 inflammasome's role in constraining liver regeneration by impairing macrophage efferocytosis (Sci Adv., 2025). Additionally, she has investigated the role of Aquaporin-5 in facilitating liver regeneration via the ROS/GSDMD pathway (Cell Signal., 2025) and how extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury (Cell Death Discov., 2024).
  • Ophthalmology and Ocular Disease Research: She has studied the retinoic acid synthesis pathway in AQP5-deficient mice and its implications for dry eye disease (Invest Ophthalmol Vis Sci., 2024). Her research has also examined the regulation of axon guidance by Slit2 and Netrin-1 signaling in lacrimal gland development (Invest Ophthalmol Vis Sci., 2023).

Prof. Chen’s research not only deepens scientific knowledge in these areas but also paves the way for novel therapeutic strategies for liver and eye diseases.

Accolades and Recognition 🏆

Prof. Chen’s contributions to medical science have been widely recognized through prestigious research grants and peer-reviewed publications. She has received:

  • National Natural Science Foundation of China (2020-2023): RMB 550,000 for research on AQP5’s protective role in lens transparency through miRNA-mediated autophagy.
  • Shandong Provincial Natural Science Foundation (2018-2021): RMB 150,000 for the identification and functional study of Fuchs corneal endothelial dystrophy gene.

Her research has been featured in top-tier scientific journals, including Science Advances, Cell Signal, Cell Death Discovery, and Investigative Ophthalmology & Visual Science, reinforcing her status as a leading expert in regenerative medicine and ophthalmology.

Impact and Influence 🌍

Prof. Chen’s work bridges fundamental research and clinical applications, making a profound impact in both ophthalmology and liver disease treatment. Her findings on macrophage efferocytosis and aquaporins have opened new avenues for therapeutic interventions in liver regeneration, while her contributions to ocular disease mechanisms have enhanced the understanding of corneal and lacrimal gland pathophysiology.

Through her mentorship, collaborations, and academic contributions, she continues to shape the next generation of medical researchers and clinicians, strengthening Qingdao University’s reputation as a hub for medical research excellence.

Legacy and Future Contributions 🚀

With an established track record in liver regeneration and ophthalmic research, Prof. Peng Chen’s future contributions are expected to drive medical innovations in regenerative medicine and precision healthcare. Her work on cellular signaling pathways, extracellular vesicles, and aquaporins will likely inspire new therapeutic breakthroughs in both systemic and ocular diseases. As she continues to lead cutting-edge research, mentor young scientists, and contribute to transformative discoveries, Prof. Chen’s legacy will be one of scientific excellence, innovation, and meaningful impact on global healthcare.

Publications


  • 📄NLRP3 inflammasome constrains liver regeneration through impairing MerTK-mediated macrophage efferocytosis

    • Journal: Science Advances
    • Year: 2025
    • Authors: Wei S, Guan G, Luan X, Yu C, Miao L, Yuan X, Chen P*, Di G*

  • 📄Aquaporin-5 facilitates liver regeneration following hepatectomy via ROS/GSDMD pathway

    • Journal: Cell Signaling
    • Year: 2025
    • Authors: Li B, Di G, Ge H, Song P, Han W, Sun H, Wang D, Chen P*, Wang Y*

  • 📄Extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury by enhancing macrophage efferocytosis via MerTK-ERK-COX2 signaling

    • Journal: Cell Death Discovery
    • Year: 2024
    • Authors: Miao L, Yu C, Guan G, Luan X, Jin X, Pan M, Yang Y, Yan J, Chen P*, Di G*

  • 📄Reticulated Retinoic Acid Synthesis is Implicated in the Pathogenesis of Dry Eye in Aqp5 Deficiency Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2024
    • Authors: Ge H, Di G, Li B, Han W, Song P, Han S, Wang D*, Chen P*

  • 📄Regulation of Axon Guidance by Slit2 and Netrin-1 Signaling in the Lacrimal Gland of Aqp5 Knockout Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2023
    • Authors: Bai Y, Di G, Ge H, Li B, Zhang K, Zhang D, Wang D*, Chen P*

 

Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

Dr. Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

University of Chieti | Italy

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Ylenia Della Rocca’s academic journey began with exceptional achievements in biotechnology. In 2018, she earned her degree in Biotechnology with a perfect score of 110/110 cum laude from the University of L'Aquila. Her thesis, centered on "Hairy Cell Leukemia," set the stage for her future in oncohematological genetics. She continued to excel with a Master’s degree in Medical Biotechnology, again graduating with academic praise. Her research on the HLA-G 3' UTR region in kidney transplantation at the National Research Center solidified her expertise in medical biotechnology.

🏥 Professional Endeavors

Currently, Dr. Della Rocca serves as a Researcher Technologist and Subject Expert in Histology and Embryology at the University of Chieti. Her impressive academic trajectory culminated in a Ph.D. in "Innovative Technologies in Clinical Medicine & Dentistry" in 2024. As part of her doctoral research, she developed a new iPS cell line during her tenure at the University of Barcelona and Josep Carreras Leukaemia Research Institute. Beyond her role as a researcher, Dr. Della Rocca has been a prominent speaker at numerous international conferences, where her work has garnered significant recognition.

🔬 Contributions and Research Focus

Dr. Della Rocca’s research is at the forefront of biotechnology and regenerative medicine. Her completed and ongoing projects include the development of three-dimensional disease models, studies on tissue differentiation, and the establishment of new iPS cell lines. She has also been pivotal in creating innovative models for carcinogenesis research. Her current patent under review—"Pluripotent Stem Cells Induced by Autologous Gingival Stem Cells and Extracellular Vesicles: A Novel Approach for Cardiac Regeneration"—underscores her groundbreaking contributions to stem cell therapies and regenerative medicine.

🏆 Accolades and Recognition

Dr. Della Rocca’s research career has been marked by numerous accolades, including two prestigious awards for her scientific achievements. She has been a Guest Editor for special issues in renowned journals like the International Journal of Molecular Sciences and has served as a Review Editor for Frontiers in Genetics and Frontiers in Cell and Developmental Biology. Her citation index of 10 reflects the growing impact of her research in the scientific community.

🌍 Impact and Influence

Dr. Della Rocca’s work transcends academic research, as evidenced by her collaborations with top universities and research institutes worldwide, including the University of Barcelona, IRCCS Sicily, and the University of Montreal. She is an active member of the Italian Society of Anatomy and Histology and the Sigma Xi Scientific Research Honor Society. Dr. Della Rocca’s commitment to healthcare is further exemplified by her founding of Associazione Sorrisi in Ospedale (A.S.I.O.), a third-sector organization aimed at improving patient care in hospitals.

🔮 Legacy and Future Contributions

As a leader in the fields of stem cells, bioengineering, and regenerative medicine, Dr. Ylenia Della Rocca continues to push the boundaries of scientific knowledge. Her contributions to cell-free therapies and the development of three-dimensional models hold immense promise for future medical applications. With her ongoing work in stem cell regeneration and epigenetic research, Dr. Della Rocca is poised to shape the next frontier of clinical and research tools, leaving a lasting legacy in biotechnology.

 

Publications


📄 Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
Authors: Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani, Jacopo Pizzicannella
Journal: International Journal of Molecular Sciences
Year: 2024


📄 Biological Effects of PMMA and Composite Resins on Human Gingival Fibroblasts: An In Vitro Comparative Study
Authors: Ylenia Della Rocca, Enrico Matteo Traini, Oriana Trubiani, Tonino Traini, Antonella Mazzone, Guya Diletta Marconi, Jacopo Pizzicannella, Francesca Diomede
Journal: International Journal of Molecular Sciences
Year: 2024